首页|期刊导航|广东医学|线粒体内膜移位酶9在肺腺癌的潜在临床意义及对恶性表型的影响

线粒体内膜移位酶9在肺腺癌的潜在临床意义及对恶性表型的影响OA

Potential clinical significance of translocase of inner mitochondrial membrane 9 in lung adenocarcinoma and its effects on malignant phenotypes

中文摘要英文摘要

目的 本研究旨在明确线粒体内膜移位酶9(translocase of inner mitochondrial membrane 9,TIMM9)在肺腺癌(lung adenocarcinoma,LUAD)中的mRNA表达特点、鉴别诊断价值及其分子调控机制.方法 本研究首先利用11个在线数据集,结合独立样本t检验及标准化均数差(standardized mean difference,SMD),对比LUAD与癌旁组织中TIMM9 mRNA的表达水平.采用实时荧光定量逆转录聚合酶链式反应(real-time quantitative reverse transcription polymerase chain reaction,RT-qPCR)检测对临床配对样本中TIMM9 mRNA水平以预实验验证数据库结果.运用受试者工作特征(receiver operating characteristic,ROC)曲线及汇总 ROC(summary receiver operating characteristic,sROC)曲线评估 TIMM9 鉴别 LUAD 的能力.在 LU-AD细胞系(H1299、A549)中进行TIMM9敲低实验,结合CCK-8、划痕和Transwell迁移实验探索其对细胞增殖、迁移和侵袭的影响,并通过富集分析预测其潜在调控通路.结果 基于随机效应模型的综合分析显示,LUAD组TIMM9 mRNA表达水平显著高于癌旁对照组(SMD=1.53,95%CI:1.05~2.01),11个数据集中9个显示其显著上调(P<0.05).10个数据集的ROC曲线下面积(area under the curve,AUC)>0.75,sROC曲线敏感度0.82、特异度0.83、AUC=0.89,提示TIMM9 mRNA鉴别LUAD效能良好.细胞功能实验证实,TIMM9敲低可显著抑制LUAD细胞的增殖及迁移能力(P<0.05),富集分析显示其主要通过cell adhesion molecule interaction、cytoskeleton in muscle cells 等信号通路调控 LUAD 发生、发展.结论 TIMM9 mRNA 在LUAD组织中存在明显差异表达上调,高表达的TIMM9 mRNA具有良好的鉴别LUAD与癌旁组织的潜力.细胞功能证实下调TIMM9可抑制LUAD细胞恶性表型进展,其可能通过细胞黏附相关信号通路参与LUAD调控.TIMM9 mRNA有望作为LUAD早期诊断、靶向治疗的潜在新型标志物.

Objective To investigate the mRNA expression characteristics,diagnostic discriminative value,and molecular regulatory mechanisms of translocase of inner mitochondrial membrane 9(TIMM9)in lung adenocarcinoma(LUAD).Methods Eleven publicly available online datasets were first analyzed.Independent-samples t-tests and standardized mean difference(SMD)analyses were performed to compare TIMM9 mRNA expression levels between LUAD tissues and adjacent non-tumor tissues.Real-time quantitative reverse transcription polymerase chain reaction(RT-qPCR)was performed to detect TIMM9 mRNA expression in clinically paired samples for preliminary validation of the da-tabase findings.Receiver operating characteristic(ROC)and summary receiver operating characteristic(sROC)curve analyses were performed to evaluate the ability of TIMM9 to discriminate LUAD from adjacent non-tumor tissues.TIMM9 knockdown experiments were performed in LUAD cell lines(H1299 and A549).Cell Counting Kit-8(CCK-8),wound-healing,and Transwell migration assays were used to investigate the effects of TIMM9 knockdown on cell prolifer-ation,migration,and invasion.Enrichment analysis was further performed to predict the potential regulatory pathways of TIMM9.Results Comprehensive analysis based on a random-effects model showed that TIMM9 mRNA expression was significantly higher in the LUAD group than in the adjacent non-tumor tissue group(SMD=1.53,95%CI:1.05-2.01),with significantly upregulated expression observed in 9 of the 11 datasets(P<0.05).The area under the ROC curve(AUC)was>0.75 in 10 datasets.The sROC analysis yielded a sensitivity of 0.82,specificity of 0.83,and AUC of 0.89,indicating good discriminatory performance of TIMM9 mRNA for LUAD.Functional assays demonstrated that TIMM9 knockdown significantly inhibited the proliferation and migration of LUAD cells(P<0.05).Enrichment analysis indicated that TIMM9 may regulate the development and progression of LUAD mainly through pathways such as cell adhe-sion molecule interactions and cytoskeleton-related signaling.Conclusion TIMM9 mRNA is significantly upregulated in LUAD tissues,and its high expression may have good potential for discriminating LUAD tissues from adjacent non-tumor tissues.Functional assays demonstrated that downregulation of TIMM9 inhibited the malignant phenotypes of LUAD cells,potentially through the regulation of cell adhesion-related signaling pathways.TIMM9 mRNA may serve as a potential no-vel biomarker for the early diagnosis and targeted therapy of LUAD.

李靖霄;蔡运凯;何钧道;何坤霖;刘俊;周华富

广西医科大学第一附属医院心胸外科(广西南宁 530021)广西医科大学第一附属医院心胸外科(广西南宁 530021)广西医科大学第一附属医院心胸外科(广西南宁 530021)广西医科大学第一附属医院心胸外科(广西南宁 530021)广西医科大学第一附属医院心胸外科(广西南宁 530021)广西医科大学第一附属医院心胸外科(广西南宁 530021)

医药卫生

肺腺癌线粒体内膜移位酶9表达恶性表型信号通路

lung adenocarcinomatranslocase of inner mitochondrial membrane 9expressionmalignant pheno-typesignaling pathway

《广东医学》 2026 (9)

1310-1319,10

国家临床重点专科建设项目(桂财社函[2022]255号)广西医疗卫生重点学科建设项目、广西壮族自治区临床重点专科建设项目(桂卫医发[2022]21号)

10.13820/j.cnki.gdyx.20261837

评论